ADVERTISEMENT
Search

February 2025

Pharmacy Today logo
Volume 31, Issue 2

Archives   Download TOC  

Current Issue

February 2025 cover

Download  

ADVERTISEMENT
 

Practice & Trends

RSS
RSS

Drugs & Diseases

A new treatment option for uncomplicated UTIs
Drugs & Diseases

New Drug

A new treatment option for uncomplicated UTIs

In October 2024, FDA approved Orlynvah (sulopenem etzadroxil and probenecid—Iterum Therapeutics) for the treatment of uncomplicated UTIs caused by E. coli, Klebsiella pneumoniae, or Proteus mirabilis in adult women who have limited or no alternative antibiotic options.

Lauren Howell, PharmD

Poisoning
Drugs & Diseases

OTCs Today

Poisoning

Most poisoning in the United States is unintentional, making prevention and treatment of such poisoning critical to public health.

Mary Warner

RSS

Health Systems

Trending Topics
Health Systems

Inpatient Insights

Trending Topics

The use of direct oral anticoagulants for stroke prevention in patients with AFib can cause a risk of bleeding and therefore limits their use. A recent study from the OCEANIC–AF Steering Committee investigated the efficacy of asundexian, an activated factor XI inhibitor that may prevent strokes with less bleeding.

APhA Staff

SGLT-2 inhibitors show promise in heart failure
Health Systems

CVD

SGLT-2 inhibitors show promise in heart failure

SGLT-2 inhibitors have demonstrated significant efficacy in the management of heart failure. The American College of Cardiology, American Heart Association, and Heart Failure Society of America recommend SGLT-2 inhibitors for patients with heart failure with reduced ejection fraction (HFrEF) due to their substantial benefits in reducing cardiovascular death and heart failure hospitalizations.

Corey Diamond, PharmD

What pharmacists need to know about infectious disease
Health Systems

Infectious Disease

What pharmacists need to know about infectious disease

The COVID-19 pandemic shined a light on pharmacists’ relevant skills and expertise in the face of an infectious disease outbreak. Now that the smoke has cleared, pharmacists have largely returned to their prepandemic duties. But a working knowledge of infectious diseases and their treatment strategies continues to be essential across all pharmacy practice settings.

Sonya Collins

RSS

CPE

RSS

In this Issue

RSS
ADVERTISEMENT